Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Taro Pharmaceuticals U.S.A., Inc. to request your refund or repair — edit it as you like.
Subject: Recall D-0134-2017 — Taro Pharmaceuticals U.S.A., Inc. Taro Pharmaceuticals U.S.A., Inc. recalls Kamedis BIO-HERBAL DAND Hello, I own a Taro Pharmaceuticals U.S.A., Inc. recalls Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% that is covered by recall D-0134-2017 from Taro Pharmaceuticals U.S.A., Inc.. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
